Literature DB >> 30447983

The microbiome of Escherichia coli and culture-negative nonsevere clinical mastitis: Characterization and associations with linear score and milk production.

A K Vasquez1, E K Ganda1, M B Capel2, S Eicker3, P D Virkler1, R C Bicalho1, D V Nydam4.   

Abstract

Culture-negative and Escherichia coli cases are uncommonly treated in pathogen-based protocols for nonsevere mastitis. High-throughput 16S rRNA sequencing might reveal the presence of other pathogens and can provide information on microbial diversity. The objective was to explore the milk microbiome at the time of the mastitis event (enrollment) and its association with survival in the herd, milk production, and postevent linear score (LS) for cows with clinical mastitis characterized as negative or E. coli by culture. Fifty E. coli-positive and 35 culture-negative samples from cases were enrolled. No cases were treated with antimicrobials. All E. coli-positive quarters were characterized as transient; microbiological culture of samples taken 15 d postmastitis were negative for this organism. However, a difference in α-diversity (Shannon index) was present between enrollment and follow-up samples (3.8 vs. 5.1). When α-diversity was explored for enrollment E. coli samples, no relationship was observed between the Shannon indices of these samples and postmastitis LS. Alpha-diversity of the enrollment samples was lower for E. coli-positive cows that subsequently had greater losses in milk production. This difference was explained by a greater relative abundance of the family Enterobacteriaceae (67.8 vs. 38.4%) for cows that dropped in production. Analysis of composition of the microbiome identified one phylum, Proteobacteria, that differed between E. coli-positive cows that dropped in production and those that did not. Evaluation of β -diversity found no statistical relationship between postmastitis LS and the microbiome. When evaluating α- and β-diversities and composition of the microbiomes for culture-negative quarters, no associations were found for milk production changes and postmastitis LS. Three cows did not remain in the herd, limiting the ability to analyze survival. The findings suggest that a contributing factor to negative outcomes in E. coli-positive cows is relative abundance of this pathogen, and that no single or collective group of bacterial families is associated with milk production changes or postmastitis LS in culture-negative quarters. Although additional studies should be performed, the absence of associations between outcomes explored and microbial profiles in this study suggests that we are not missing opportunities by not treating nonsevere E. coli or culture-negative mastitis cases.
Copyright © 2019 American Dairy Science Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Escherichia coli; mastitis; metagenomics; milk microbiome

Mesh:

Substances:

Year:  2018        PMID: 30447983     DOI: 10.3168/jds.2018-15062

Source DB:  PubMed          Journal:  J Dairy Sci        ISSN: 0022-0302            Impact factor:   4.034


  3 in total

1.  Changes in bovine milk bacterial microbiome from healthy and subclinical mastitis affected animals of the Girolando, Gyr, Guzera, and Holstein breeds.

Authors:  Raphael S Steinberg; Lilian C Silva E Silva; Marcelo R de Souza; Ronaldo B Reis; Patrícia C L da Silva; Gustavo A Lacorte; Jacques R Nicoli; Elisabeth Neumann; Álvaro C Nunes
Journal:  Int Microbiol       Date:  2022-07-15       Impact factor: 3.097

2.  A core microbiota dominates a rich microbial diversity in the bovine udder and may indicate presence of dysbiosis.

Authors:  Davide Porcellato; Roger Meisal; Alberto Bombelli; Judith A Narvhus
Journal:  Sci Rep       Date:  2020-12-10       Impact factor: 4.379

3.  Effects of the supplementation of a calcium soap containing medium-chain fatty acids on the fecal microbiota of pigs, lactating cows, and calves.

Authors:  Hiroki Matsui; Taichi Imai; Makoto Kondo; Tomomi Ban-Tokuda; Yutaka Yamada
Journal:  Anim Sci J       Date:  2021-12       Impact factor: 1.974

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.